Physician profile
Ashley N Wallner
NPI 1952748923
$2,198.05
in general payments reported to CMS, 2019-2025
9 companies · $2,003 in 2025
The $2,003 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.55 · 2022: $20.65 · 2023: $36.61 · 2024: $118 · 2025: $2,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,082 · Food and Beverage: $940 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,082.05 |
| Food and Beverage | $939.81 |
| Education | $135.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,869.13 | 2021-2025 | Interstim, Nuro |
| Seagen INC. | $99.99 | 2025 | |
| Coloplast Corp | $69.24 | 2023-2024 | Speedicath |
| Galderma Laboratories, L.P. | $41.21 | 2024 | |
| Pfizer INC. | $37.18 | 2025 | |
| Merck Sharp & Dohme LLC | $25.81 | 2025 | Welireg, Keytruda |
| Innovation Technologies INC | $20.65 | 2022 | |
| Janssen Biotech, INC. | $19.48 | 2023 | |
| Abbvie INC. | $15.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Wallner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.